← Eichor · All briefs

NCT02930109 — Acute Leukemia trial site landscape

Public-registry site landscape for NCT02930109, a Acute Leukemia study sponsored by Prescient Therapeutics, Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.

TrialNCT02930109 (registry record)
SponsorPrescient Therapeutics, Ltd.
Condition(s)Acute Leukemia
PhasePHASE1 / PHASE2
Listed sites2
Site countriesUnited States

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT02930109 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.